Pentobarbital features throughout the CNS by binding to gamma-aminobutyric acid (GABA) A subtype receptors. This motion potentiates GABA effects, resulting in CNS despair and inhibiting glutamate, further more leading to an additive effect on CNS melancholy. Although the deficiency of an antidote has led to diminished initially-line use in the drug